201 related articles for article (PubMed ID: 21134357)
1. Limonene, a natural cyclic terpene, is an agonistic ligand for adenosine A(2A) receptors.
Park HM; Lee JH; Yaoyao J; Jun HJ; Lee SJ
Biochem Biophys Res Commun; 2011 Jan; 404(1):345-8. PubMed ID: 21134357
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A(2A) receptor agonist and adenosine A(3) receptor antagonist activity.
Bevan N; Butchers PR; Cousins R; Coates J; Edgar EV; Morrison V; Sheehan MJ; Reeves J; Wilson DJ
Eur J Pharmacol; 2007 Jun; 564(1-3):219-25. PubMed ID: 17382926
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive profile of 2-thienyl-3,4-methylenedioxybenzoylhydrazone is mediated by activation of the A2A adenosine receptor.
Leal CM; Pereira SL; Kümmerle AE; Leal DM; Tesch R; de Sant'Anna CM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
Eur J Med Chem; 2012 Sep; 55():49-57. PubMed ID: 22857782
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
[TBL] [Abstract][Full Text] [Related]
5. Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2.
Schulte G; Fredholm BB
Mol Pharmacol; 2000 Sep; 58(3):477-82. PubMed ID: 10953039
[TBL] [Abstract][Full Text] [Related]
6. Cocaine produces D2R-mediated conformational changes in the adenosine A(2A)R-dopamine D2R heteromer.
Marcellino D; Navarro G; Sahlholm K; Nilsson J; Agnati LF; Canela EI; Lluís C; Århem P; Franco R; Fuxe K
Biochem Biophys Res Commun; 2010 Apr; 394(4):988-92. PubMed ID: 20307491
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of 2-hydrazinyladenosine derivatives as A(2A) adenosine receptor ligands.
El-Tayeb A; Gollos S
Bioorg Med Chem; 2013 Jan; 21(2):436-47. PubMed ID: 23245803
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA
J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659
[TBL] [Abstract][Full Text] [Related]
9. A2A adenosine receptor ligand binding and signalling is allosterically modulated by adenosine deaminase.
Gracia E; Pérez-Capote K; Moreno E; Barkešová J; Mallol J; Lluís C; Franco R; Cortés A; Casadó V; Canela EI
Biochem J; 2011 May; 435(3):701-9. PubMed ID: 21306300
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
[TBL] [Abstract][Full Text] [Related]
11. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
[TBL] [Abstract][Full Text] [Related]
12. Kinetic and functional properties of [3H]ZM241385, a high affinity antagonist for adenosine A2A receptors.
Uustare A; Vonk A; Terasmaa A; Fuxe K; Rinken A
Life Sci; 2005 Feb; 76(13):1513-26. PubMed ID: 15680315
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of dual acting antioxidant A(2A) adenosine receptor agonists.
Hausler NE; Devine SM; McRobb FM; Warfe L; Pouton CW; Haynes JM; Bottle SE; White PJ; Scammells PJ
J Med Chem; 2012 Apr; 55(7):3521-34. PubMed ID: 22432713
[TBL] [Abstract][Full Text] [Related]
14. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.
Lebon G; Warne T; Edwards PC; Bennett K; Langmead CJ; Leslie AG; Tate CG
Nature; 2011 May; 474(7352):521-5. PubMed ID: 21593763
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptor.
Deflorian F; Kumar TS; Phan K; Gao ZG; Xu F; Wu H; Katritch V; Stevens RC; Jacobson KA
J Med Chem; 2012 Jan; 55(1):538-52. PubMed ID: 22104008
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes.
Torvinen M; Marcellino D; Canals M; Agnati LF; Lluis C; Franco R; Fuxe K
Mol Pharmacol; 2005 Feb; 67(2):400-7. PubMed ID: 15539641
[TBL] [Abstract][Full Text] [Related]
17. Effects of adenosine A(2A) and A(2B) receptor activation on signaling pathways and cytokine production in human uroepithelial cells.
Säve S; Persson K
Pharmacology; 2010; 86(3):129-37. PubMed ID: 20689344
[TBL] [Abstract][Full Text] [Related]
18. Novel amino acid derived natural products from the ascidian Atriolum robustum: identification and pharmacological characterization of a unique adenosine derivative.
Kehraus S; Gorzalka S; Hallmen C; Iqbal J; Müller CE; Wright AD; Wiese M; König GM
J Med Chem; 2004 Apr; 47(9):2243-55. PubMed ID: 15084123
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel dual-action compounds targeting the adenosine A(2A) receptor and adenosine transporter for neuroprotection.
Chen JB; Liu EM; Chern TR; Yang CW; Lin CI; Huang NK; Lin YL; Chern Y; Lin JH; Fang JM
ChemMedChem; 2011 Aug; 6(8):1390-400. PubMed ID: 21692183
[TBL] [Abstract][Full Text] [Related]
20. N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
Beukers MW; Wanner MJ; Von Frijtag Drabbe Künzel JK; Klaasse EC; IJzerman AP; Koomen GJ
J Med Chem; 2003 Apr; 46(8):1492-503. PubMed ID: 12672250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
